Carles Codony
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
Papers in
-
- Cancer Mechanisms and Therapy 6
- Lymphoma Diagnosis and Treatment 4
-
- Lung Cancer Treatments and Mutations 11
- Co-authors
- Gurman Singh Pall (1 shared paper)Andrew John Hamilton (1 shared paper)John C. Byrne (1 shared paper)Niki Karachaliou (15 shared papers)R Cebolla Rosell (15 shared papers)Jordi Codony‐Servat (11 shared papers)Dolors Serra (4 shared papers)Fausto G. Hegardt (4 shared papers)
In The Last Decade
Carles Codony
30 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 92
- Cancer Research 382
- Molecular Biology 972
- Oncology 330
- Pulmonary and Respiratory Medicine 289
- Genetics 87
Countries citing papers authored by Carles Codony
This map shows the geographic impact of Carles Codony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carles Codony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carles Codony more than expected).
Fields of papers citing papers by Carles Codony
This network shows the impact of papers produced by Carles Codony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carles Codony. The network helps show where Carles Codony may publish in the future.
Co-authors
The 25 scholars most cited alongside Carles Codony, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 402 | |
| 2 | 2017 | 192 | |
| 3 | 2009 | 145 | |
| 4 | 2017 | 130 | |
| 5 | 1998 | 119 | |
| 6 | 2019 | 97 | |
| 7 | 2018 | 71 | |
| 8 | 2015 | 58 | |
| 9 | 2011 | 53 | |
| 10 | 2017 | 45 | |
| 11 | 2019 | 41 | |
| 12 | 2019 | 35 | |
| 13 | 2012 | 33 | |
| 14 | 2019 | 28 | |
| 15 | 2009 | 20 | |
| 16 | 2019 | 14 | |
| 17 | 2020 | 13 | |
| 18 | 2019 | 12 | |
| 19 | 2019 | 12 | |
| 20 | 2001 | 6 |
About Carles Codony
Carles Codony is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Genetics, having authored 32 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cancer Mechanisms and Therapy (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Quinazolinone synthesis and applications (3 papers). The work is most often cited by research in Cancer Research (382 citations), Molecular Biology (972 citations), Oncology (330 citations), Pulmonary and Respiratory Medicine (289 citations) and Genetics (87 citations). Carles Codony has collaborated with scholars based in Spain, Italy and Japan. Frequent co-authors include Gurman Singh Pall, Andrew John Hamilton, John C. Byrne, Niki Karachaliou, R Cebolla Rosell, Jordi Codony‐Servat, Dolors Serra, Fausto G. Hegardt, Guillermina Asins and Ana A. Giménez-Capitán. Their work appears in journals such as Translational Lung Cancer Research, Journal of Thoracic Oncology, Blood, Nature Communications and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.